India Pharma Companies
-
{
- All
- News
- Videos
- Web Stories
-
India's Pharma Opportunity: Expanding Global Reach In A Changing Healthcare Landscape
India's pharmaceutical industry is now at a critical juncture in its evolution.
-
Central Drugs Body Revamps Testing Permissions To Fast-Track Drug Approvals in India
India's drug regulator Central Drugs Standard Control Organization has revised testing permission norms to speed up approvals. From June 1, 2026, companies can start lab testing immediately after application, a step aimed at reducing delays while mai
-
India-US Trade Deal Likely To Offer Tariff Relief On Exported Medicines
India's pharmaceutical industry has welcomed the interim trade agreement framework between India and the US, which offers tariff relief on medicines and several other Indian exports.
-
India-EU Trade Pact Explained: $572 Billion Boost To Indian Pharma, MedTech Industry
The India-EU Free Trade Agreement opens access to the European Union's $572.3 billion pharmaceuticals and medical devices market, boosting India's pharma sector, employment, MSMEs and global supply chain integration, according to the government.
-
Indian Drugmakers Recall Medicines In The US Over Manufacturing Issues
Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Drug Administration (USFDA).
-
$100 Million Boost For India-Afghanistan Trade Marks Setback for Pakistan
In a significant development that signals a new phase of India-Afghanistan economic cooperation and a blow to Pakistan's regional trade influence, leading pharmaceutical companies from India and Afghanistan have signed a $100 million MoU.
-
India To Become Global Innovation-Led Pharma Giant In 5 Years: Central Drugs Body Says
India is well positioned to evolve from being the pharmacy of the world to an innovation-led pharma nation over the next five years, said Dr. R Chandrashekar, Joint Drugs Controller, the Central Drugs Standard Control Organization (CDSCO).
-
New Study Highlights Drug Pricing And Regulation Issues In India
A new government study exposes serious flaws in India's drug pricing and regulation infrastructure. This study reveals how systemic failures impact drug pricing.
-
Novo Nordisk Partners With Emcure To Launch Weight Loss Drug Poviztra In India
Emcure Pharma becomes the first Indian company to hold exclusive rights to distribute and commercialise Poviztra, a semaglutide injection 2.4 mg for weight loss, the statement said.
-
364 Violations Found At Pharma Company Behind 'Killer' Cough Syrup: Sources
The pharmaceutical company, Sresan Pharma, at the centre of the cough syrup tragedy that has claimed over a dozen children's lives in Madhya Pradesh was found to be supplying the cough syrup without testing it, said a top source.
-
India's Pharma Opportunity: Expanding Global Reach In A Changing Healthcare Landscape
India's pharmaceutical industry is now at a critical juncture in its evolution.
-
Central Drugs Body Revamps Testing Permissions To Fast-Track Drug Approvals in India
India's drug regulator Central Drugs Standard Control Organization has revised testing permission norms to speed up approvals. From June 1, 2026, companies can start lab testing immediately after application, a step aimed at reducing delays while mai
-
India-US Trade Deal Likely To Offer Tariff Relief On Exported Medicines
India's pharmaceutical industry has welcomed the interim trade agreement framework between India and the US, which offers tariff relief on medicines and several other Indian exports.
-
India-EU Trade Pact Explained: $572 Billion Boost To Indian Pharma, MedTech Industry
The India-EU Free Trade Agreement opens access to the European Union's $572.3 billion pharmaceuticals and medical devices market, boosting India's pharma sector, employment, MSMEs and global supply chain integration, according to the government.
-
Indian Drugmakers Recall Medicines In The US Over Manufacturing Issues
Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Drug Administration (USFDA).
-
$100 Million Boost For India-Afghanistan Trade Marks Setback for Pakistan
In a significant development that signals a new phase of India-Afghanistan economic cooperation and a blow to Pakistan's regional trade influence, leading pharmaceutical companies from India and Afghanistan have signed a $100 million MoU.
-
India To Become Global Innovation-Led Pharma Giant In 5 Years: Central Drugs Body Says
India is well positioned to evolve from being the pharmacy of the world to an innovation-led pharma nation over the next five years, said Dr. R Chandrashekar, Joint Drugs Controller, the Central Drugs Standard Control Organization (CDSCO).
-
New Study Highlights Drug Pricing And Regulation Issues In India
A new government study exposes serious flaws in India's drug pricing and regulation infrastructure. This study reveals how systemic failures impact drug pricing.
-
Novo Nordisk Partners With Emcure To Launch Weight Loss Drug Poviztra In India
Emcure Pharma becomes the first Indian company to hold exclusive rights to distribute and commercialise Poviztra, a semaglutide injection 2.4 mg for weight loss, the statement said.
-
364 Violations Found At Pharma Company Behind 'Killer' Cough Syrup: Sources
The pharmaceutical company, Sresan Pharma, at the centre of the cough syrup tragedy that has claimed over a dozen children's lives in Madhya Pradesh was found to be supplying the cough syrup without testing it, said a top source.
